Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningeal Carcinomatosis × tucatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Neoplasms 3 Neoplasm Metastasis 3 Meningeal Neoplasms 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Pathologic Complete Response 1 Multiple Myeloma 1 Metastatic Breast Cancer With a Isolated Brain Progression 1 Meningeal Carcinomatosis 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hemangiosarcoma 1 HER2-positive Breast Cancer 1 Central Nervous System Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma 1

Interventions

Pemetrexed 18 Bevacizumab 8 Radiotherapy 7 Spinal Puncture 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 osimertinib 4 aflutinib 3 Trastuzumab 3 Temozolomide 3 Methotrexate 3 Dexamethasone 3 trastuzumab deruxtecan 2 pembrolizumab 2 merphos 2 lorlatinib 2 Vitamin B 12 2 Topotecan 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Folic Acid 2 Drug Therapy 2 Cytarabine 2 Cyclophosphamide 2 tucatinib 1 toripalimab 1 sintilimab 1 sacituzumab govitecan 1 pertuzumab 1 peginterferon alfa-2b 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05800275 2025-11-18

ETIC-LM

UNICANCER

Phase 2 Recruiting

Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡